Karyopharm Therapeutics (KPTI) PT Raised to $40 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts KPTI Hot Sheet
Price: $1.06 -2.75%
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
H.C. Wainwright analyst Edward White raised the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $40.00 (from $37.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
- swedbank ab (SWEDA:SS) (SWDBF) PT Raised to SEK237 at Barclays
- Central Asia Metals Plc. (CAML:LN) PT Raised to GBP2.15 at Canaccord Genuity
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
